NCT03111420View on ClinicalTrials.gov

Study of AggreGuide A-100 (ADP) Assay

NACompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

January 9, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Risk Factor, CardiovascularPlatelet Dysfunction Due to Drugs
Interventions
DRUG

P2Y12 inhibitor

Administration of P2Y12 inhibitor antiplatelet therapy

DEVICE

Platelet function test

Blood is drawn for testing of platelet aggregation activity

Sponsors

Lead Sponsor

Aggredyne, Inc.
All Listed Sponsors
lead

Aggredyne, Inc.

INDUSTRY

NCT03111420 - Study of AggreGuide A-100 (ADP) Assay | Biotech Hunter | Biotech Hunter